Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
The summary for the Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required): This funding opportunity aims to support high risk clinical trials for the development of in vivo high-resolution structural and functional imaging technologies for the living human inner ear. Proposed projects should focus on improving the resolution of current imaging techniques or developing new imaging techniques that can visualize inner ear structures in vivo with significantly greater detail and accuracy than currently possible. Structural and functional aspects, including visualizing dynamic elements, are important to developing new and improved techniques. Projects may also focus on developing new imaging probes or contrast agents that can enhance visualization of the inner ear structures. Research supported in response to this RFA is expected to significantly advance the ability to visualize auditory and vestibular components, such as hair cells, otoliths, membranes, ions, and vasculature, in detail in awake patients in a clinical setting using non-invasive techniques. To achieve this goal, a multidisciplinary team approach that takes advantage of the expertise of each team member is highly encouraged. Studies in humans must be proposed to develop,advance, or test the needed technology. Any intermediate studies must articulate a clear path of the proposed methodology to application in awake humans or define the limitations and the usefulness in anesthetized humans.
Federal Grant Title: | Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-DC-25-003 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.173 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | October 1st, 2026 |
Original Application Deadline: | October 1st, 2026 |
Posted Date: | January 6th, 2025 |
Creation Date: | January 6th, 2025 |
Archive Date: | November 6th, 2026 |
Total Program Funding: | $500,000 |
Maximum Federal Grant Award: | $500,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | January 6th, 2025 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/rfa-files/RFA-DC-25-003.html
- Grant Announcement Contact
- NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32)
- • Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
- • Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
- • In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
- • NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical...
- • NIDCD Patient-Oriented Research Grant (R21)
- • Cell Lineage and Developmental Studies in Hearing and Balance
- • Structural Analyses of the Ligand-Binding Properties of Taste and Smell Receptors
- More Grants from the National Institutes of Health
- • Single Source: National Centralized Repository for Alzheimer's Disease and Related Dementi...
- • Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial O...
- • Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Acces...
- • Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed...
- • Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiate...